Table 2.
Treatment matrix for vascular risk factors
| Risk factor | Medication | Other treatments |
|---|---|---|
| Migraine | Tricyclics | Migraine trigger elimination |
| Calcium channel blockers | Magnesium supplements | |
| Carbonic anhydrase inhibitors | Refer treatment failures to neurology | |
| Topiramate | ||
| Acetazolamide | ||
| Dyslipidemia | Statins | Nutritional counseling |
| Low-dose aspirin | ||
| Diuretic | ||
| Obesity | Low-dose aspirin | Nutritional counseling |
| Hypertension | Low-dose aspirin antihypertensives | Coordinate management with internist |
| Diuretics | ||
| Beta blockers | ||
| Calcium channel blockers | ||
| Smoking | Low-dose aspirin | Smoking cessation program |
| Diuretic | ||
| Statins | ||
| Diabetes | Low-dose aspirin | Referral to endocrinology |
| Diuretic | ||
| Statins | ||
| Sleep apnea | Low-dose aspirin | CPAP or surgical treatments |
| Diuretic | ||
| Myocardial infarction, stroke | Low-dose aspirin | Coordinate management with internist |
| Transient ischemic attacks | Diuretic | |
| Known atherosclerotic disease | Statins | |
| Autoimmune disease | Transtympanic or oral steroids | Referral to rheumatology |
| Diuretic | ||
| Coagulopathies | Low-dose aspirin | Referral to hematology |
| Diuretic |
Abbreviation: CPAP, continuous positive airway pressure.